Fiduciary Trust’s ProMIS Neurosciences PMN Stock Holding History

Fiduciary Trust’s Portfolio PMN Stock Details PMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,143	Closed	-$12.1K	–	881
2025 Q3	$12.1K	Hold	1,143	–	–	﹤0.01%	847
2025 Q2	$13.8K	Buy	1,143 +400	+54%	+$5.46K	﹤0.01%	826
2025 Q1	$12.9K	Buy	743 +200	+37%	+$4.25K	﹤0.01%	817
2024 Q4	$12.9K	Sell	543 -257	-32%	-$6.4K	﹤0.01%	687
2024 Q3	$25K	Hold	800	–	–	﹤0.01%	652
2024 Q2	$30K	Hold	800	–	–	﹤0.01%	627
2024 Q1	$38.2K	Hold	800	–	–	﹤0.01%	640
2023 Q4	$23K	Hold	800	–	–	﹤0.01%	620
2023 Q3	$39.6K	Buy	800 +394	+97%	+$25.6K	﹤0.01%	606
2023 Q2	$39.4K	Hold	406	–	–	﹤0.01%	621
2023 Q1	$48K	Hold	406	–	–	﹤0.01%	608
2022 Q4	$44.1K	Buy	+406	New	+$56.8K	﹤0.01%	616

Other funds holding PMN

ABG

Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

DEM

Disciplined Equity Management Neptune Beach, Florida $226M AUM 27.21% 1-Year Est. Return

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Fiduciary Trust's PMN Position: Q4 2025 in Review

Fiduciary Trust sold out of ProMIS Neurosciences (PMN) in Q4 2025, closing a stake of 1,143 shares — an estimated $12.1K sold.

Fiduciary Trust first reported a position in PMN in Q4 2022 and held it in 12 quarters. The position peaked at $48K in Q1 2023. 9 funds tracked by Wall St. Rank hold PMN as of Q4 2025.

Fiduciary Trust reported no remaining ProMIS Neurosciences position as of Q4 2025 after selling out during the quarter.
Fiduciary Trust sold 1,143 ProMIS Neurosciences shares in Q4 2025, an estimated $12.1K.
Fiduciary Trust first reported a position in ProMIS Neurosciences in Q4 2022 and held it in 12 quarters.
Fiduciary Trust's ProMIS Neurosciences position peaked at $48K in Q1 2023.
9 funds tracked by Wall St. Rank held ProMIS Neurosciences as of Q4 2025.

Based on Fiduciary Trust's 13F filing for Q4 2025, filed 13 Feb 2026.